Monte Rosa TherapeuticsGLUE
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 75 institutions reported holding Monte Rosa Therapeutics Inc. (GLUE) in their 13F filings, up 7 from Q1 2024. 12 opened new positions and 6 sold out. The largest holders were NEA Management Company, LLC ($28.8M), T. Rowe Price Associates Inc. ($22.4M) and FMR LLC ($19.1M). 4 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio).
- Company
- Monte Rosa Therapeutics Inc.
- CUSIP
- 61225M102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $15.2M |
| Exits | 6 | $380K |
All 13F filers, Q1 2024 → Q2 2024: 6,722,086 shares bought and 731,049 shares sold, net +5,991,037 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 75 holders
| NEA Management Company, LLC | 2.16% | No change | 7,692,298 | $28.8M |
| T. Rowe Price Associates Inc. | 0.00% | Add +17.3% | 5,977,587 | $22.4M |
| FMR LLC | 0.00% | Reduce -4.6% | 5,094,974 | $19.1M |
| Baker Bros. Advisors LP | 0.24% | No change | 4,916,095 | $18.4M |
| Avoro Capital Advisors LLC | 0.23% | No change | 4,535,000 | $17.0M |
| Montanova Capital, LLC | 0.41% | New | 2,659,000 | $9.9M |
| Vanguard Group Inc. | 0.00% | Add +55.7% | 2,547,075 | $9.5M |
| BlackRock Inc. | 0.00% | Add +2.3% | 2,360,093 | $8.8M |
| Aisling Capital Management LP | 2.38% | No change | 1,472,331 | $5.5M |
| Alphabet Inc. | 0.28% | No change | 1,464,015 | $5.5M |
| Citadel Advisors | 0.00% | Add +1.6% | 995,943 | $3.7M |
| Vestal Point Capital, LP | 0.25% | New | 890,000 | $3.3M |
| Geode Capital Management, LLC | 0.00% | Add +15.2% | 847,442 | $3.2M |
| State Street Corp. | 0.00% | Add +3.4% | 636,084 | $2.4M |
| Sphera Funds Management LTD. | 0.23% | New | 375,000 | $1.4M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +24.4% | 311,800 | $1.2M |
| ExodusPoint Capital Management, LP | 0.01% | Add +15.8% | 307,319 | $1.1M |
| Northern Trust Corp. | 0.00% | Add +1.3% | 294,196 | $1.1M |
| Casdin Capital, LLC | 0.07% | Reduce -48.9% | 261,014 | $976K |
| Renaissance Technologies | 0.00% | Add +108.6% | 254,714 | $953K |
| TD Asset Management Inc | 0.00% | Add +0.3% | 193,696 | $724K |
| Wellington Management Group LLP | 0.00% | Add +38.1% | 166,671 | $623K |
| Dimensional Fund Advisors LP | 0.00% | Add +111.6% | 153,758 | $575K |
| Bank of New York Mellon Corp | 0.00% | Add +16.9% | 109,864 | $411K |
| Manufacturers Life Insurance Company, The | 0.00% | Reduce -0.4% | 102,709 | $384K |
| Acadian Asset Management LLC | 0.00% | Add +77.4% | 98,557 | $366K |
| Goldman Sachs Group Inc. | 0.00% | Add +485.8% | 92,349 | $345K |
| Nuveen Asset Management, LLC | 0.00% | No change | 89,096 | $333K |
| Bank of America Corp. | 0.00% | Add +10.3% | 68,503 | $256K |
| Morgan Stanley | 0.00% | Add +22.6% | 68,342 | $256K |
| Jane Street Group, LLC | 0.00% | Add +205.7% | 67,746 | $253K |
| Sarasin & Partners LLP | 0.00% | No change | 65,081 | $243K |
| EntryPoint Capital, LLC | 0.11% | Add +304.8% | 64,339 | $241K |
| American Century Companies Inc. | 0.00% | Add +46.0% | 49,410 | $185K |
| Rhumbline Advisers | 0.00% | Add +3.0% | 47,925 | $179K |
| State of Wisconsin Investment Board | 0.00% | Reduce -13.8% | 45,500 | $170K |
| Cornercap Investment Counsel Inc. | 0.03% | Reduce -1.1% | 41,917 | $157K |
| Long Corridor Asset Management Ltd | 0.18% | No change | 40,000 | $150K |
| Exchange Traded Concepts, LLC | 0.00% | Reduce -23.7% | 35,686 | $133K |
| Alliancebernstein L.P. | 0.00% | Add +39.1% | 32,780 | $123K |
| Gsa Capital Partners LLP | 0.01% | New | 25,346 | $95K |
| D. E. Shaw & Co. | 0.00% | New | 23,422 | $88K |
| UBS Group AG | 0.00% | Reduce -43.4% | 23,294 | $87K |
| Squarepoint Ops LLC | 0.00% | New | 22,665 | $85K |
| Millennium Management | 0.00% | Reduce -86.0% | 20,928 | $78K |
| Castleview Partners, LLC | 0.04% | New | 18,950 | $71K |
| Qube Research & Technologies Ltd | 0.00% | New | 16,566 | $62K |
| Corebridge Financial, Inc. | 0.00% | — | 16,394 | $61K |
| Jump Financial, LLC | 0.00% | Reduce -3.3% | 16,338 | $61K |
| Wells Fargo & Company | 0.00% | Add +23.4% | 16,308 | $61K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | — | 16,270 | $61K |
| Legal & General Group Plc | 0.00% | No change | 15,803 | $59K |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | New | 15,600 | $58K |
| State Board of Administration of Florida Retirement System | 0.00% | Add +0.9% | 14,950 | $56K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +2477.0% | 13,452 | $50K |
| JPMorgan Chase & Co. | 0.00% | Add +4.7% | 13,418 | $50K |
| New York State Common Retirement Fund | 0.00% | Add +0.3% | 12,174 | $46K |
| Voya Investment Management LLC | 0.00% | Add +5.6% | 11,153 | $42K |
| Barclays PLC | 0.00% | Reduce -49.4% | 11,009 | $41K |
| Deutsche Bank AG | 0.00% | Reduce -18.9% | 10,860 | $41K |
| Meeder Asset Management Inc. | 0.00% | New | 10,050 | $38K |
| Citigroup Inc. | 0.00% | Add +61.7% | 9,538 | $36K |
| Royal Bank of Canada | 0.00% | Add +248.3% | 4,187 | $16K |
| STRS Ohio | 0.00% | No change | 3,100 | $12K |
| Nisa Investment Advisors, LLC | 0.00% | Add +20815.4% | 2,719 | $10K |
| Russell Investments Group, Ltd. | 0.00% | New | 2,631 | $10K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 2,241 | $8K |
| California State Teachers Retirement System | 0.00% | Reduce -29.0% | 2,208 | $8K |
| Amalgamated Bank | 0.00% | No change | 995 | $4K |
| Osaic Holdings, Inc. | 0.00% | Add +161.5% | 1,046 | $4K |
| Comerica Bank | 0.00% | No change | 841 | $3K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 300 | $1K |
| GAMMA Investing LLC | 0.00% | No change | 52 | $194 |
| PNC Financial Services Group, Inc. | 0.00% | New | 28 | $105 |
| Cwm, LLC | 0.00% | Add +950.0% | 21 | $0 |
"% of holder's portfolio" is GLUE's weight in each manager's 13F, not the share of Monte Rosa Therapeutics Inc. the manager owns.